Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global cryopreservation equipment market, by equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by end-user (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 4.318.1 million in 2017 and is expected to exhibit a CAGR of 13.2% over the forecast period (2017-2025).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1356
Cryopreservation equipment aid in cryopreserving biological samples by preventing the dehydration and formation of intracellular ice crystals. These equipment comprise controlled-rate freezers, freezing racks and holders, cryogenic incubators, cryopreservation loading chambers and tanks, thermocouple sensor for temperate detection, storage sample chambers, vapor and liquid phase storage, and canister and cane systems.
The growing demand for fertility treatments, such as in-vitro fertilization (IVF) treatment and therapies, for women and higher effectiveness of frozen embryos in the IVF procedures act as major growth drivers for the global cryopreservation equipment market. For instance, research findings published in the TIME Health, in January 2018, conducted a study including 3,000 women in Vietnam who underwent IVF procedures, and were randomly assigned to receive frozen or fresh embryo. 36% of the women implanted with frozen embryo had live births, as compared to the 31% of them who were implanted with fresh embryo.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1356
Frozen embryos lowered the risk of ovarian hyperstimulation syndrome by 7.1% to 10.3%, as compared to using fresh embryos. Freezing embryos offers couples the advantage of genetic testing, to reduce the chance of the genetic diseases prior implantation of the embryo. The umbilical cord blood (UCB) stem cells is non-invasive alternative source of hematopoietic stem cells to treat a variety of blood and bone marrow diseases, blood cancers, metabolic disorders, and immune deficiencies.
In a study published in the Banking Umbilical Cord Blood (UCB) Stem Cells awareness, attitude and expectations of donor, in May 2016, it was reported that pregnant women, especially in the emerging economies, show lower awareness regarding UCB. The study was conducted on 300 women, among whom only 26.5% were aware of UCB, 31% were aware of the private cord blood banking, while only 16% were aware of public cord blood banking.
Browse Press Release: https://bit.ly/3mVj1Dn
Key Takeaways:
- Among equipment types, the freezers segment holds a dominant position in the global market in 2017, as the freezers are an inevitable equipment used in most of the cryopreservation procedures.
- The liquid nitrogen segment leads the global market, due to the rising implementation of liquid nitrogen for preserving biological samples in vapor and liquid phases for prolonged time periods.
- In terms of application, the cord blood stem cells segment is the largest segment, owing to increasing number of patients undergoing IVF procedures.
- The stem cell research laboratory end-use segment holds a dominant position in the market, supported by the increasing application of stem cells in the treatment of various diseases, such as leukemia, hematopoietic disorders, and autoimmune disease.
- The renowned players operating in the global cryopreservation equipment market are Thermo Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory Equipment Development Co., Ltd.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1356
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
